You just read:

Sprout Pharmaceuticals Resubmits Flibanserin New Drug Application For The Treatment Of Hypoactive Sexual Desire Disorder In Premenopausal Women

News provided by

Sprout Pharmaceuticals

17 Feb, 2015, 08:00 ET